PLUVICTO - LUTETIUM LU 177 VIPIVOTIDE TETRA 27mCi/ML
Veterans Affairs, Department of · VETERANS AFFAIRS, DEPARTMENT OF
This notice is not accepting responses.
Page kept for research and related open opportunities below. For current work in this category, use the related notices or browse hubs.
- Response deadline
- Not listed
- Posted
- Oct 2, 2025
- Solicitation
- 36C26126F0007
- Set-aside
- None listed
- Place of performance
- Palo Alto, CA, USA
- Contracting office
- 261-NETWORK CONTRACT OFFICE 21 (36C261) · MATHER · CA
- Source
- SAM.gov · updated Jul 5, 2026
Description
THIS IS A PUBLIC NOTICE AND NOT A REQUEST FOR QUOTE. This is the sole source notification for the contract awarded to NOVARTIS PHARMACEUTICALS CORPORATION 59 ROUTE 10, EAST HANOVER NJ 07936. This contract is for PLUVICTO - LUTETIUM LU 177 VIPIVOTIDE TETRA 27mCi/ML.
What similar awards have paid
Real federal awards already on the books in a similar lane — so you can size the opportunity, not guess. This is public history, not a bid price, cost estimate, or prediction that you will win.
Typical award size
$36,321
Middle of the pack for similar past awards
Most similar awards fall between $8,499 and $203,138
Who has won work like this
Public awardees in this lane — useful for competitor scan or teaming ideas, not a ranked list of “best” firms.
- 1MCKESSON CORPORATION2023 awards$11.98B
- 2BAVARIAN NORDIC A/S1 award$1.17B
- 3EMERGENT BIOSOLUTIONS CANADA INC2 awards$624.99M
- 4CHARTWELL RX LLC3 awards$254.44M
- 5ALVOGEN, INC.1 award$227.68M
- 6MERCK SHARP & DOHME LLC31 awards$157.47M
- 7GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC.1 award$130.32M
- 8ELUSYS THERAPEUTICS INC1 award$124.52M
Drawn from official USAspending contract records in our index. Always confirm requirements on the SAM.gov notice before you bid.
Intelligence only — not legal advice or a guarantee of award. Always verify requirements on the official SAM.gov notice. Past award amounts are public history, not a suggested bid or prediction. Notice ID 989e5b8b353642b8a071507670bdb678.